Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Dementia Discovery Fund

This page shows the latest Dementia Discovery Fund news and features for those working in and with pharma, biotech and healthcare.

Merck & Co signs deal with Amathus for neurodegenerative diseases

Merck & Co signs deal with Amathus for neurodegenerative diseases

External collaborations that supplement and complement our internal pipeline programmes remain a cornerstone of Merck’s discovery strategy,” she added. ... The company is funded by Sanofi Ventures, as well as the Dementia Discovery Fund.

Latest news

More from news
Approximately 2 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Detecting Alzheimer’s ahead of a cure Detecting Alzheimer’s ahead of a cure

    A new company has been created from Alzheimer’s Research UK’s Drug Discovery Alliance, which will build on the work of the charity’s UCL Drug Discovery Institute. ... This newly formed biotech company, named AstronauTx, has recently received £6.5m

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    The venture capital approach to dementia research. The Dementia Discovery Fund is a venture capital fund focused on discovering and developing novel therapies for dementia, first set up in October 2015. ... Angus Grant, CEO of the Dementia Discovery Fund,

  • 30 Women Leaders in UK Healthcare (part 2) 30 Women Leaders in UK Healthcare (part 2)

    In the meantime, she is challenging not just the accepted ways of conducting drug discovery, but also some of the male behaviour that can mar the working environment. ... the UK’s new Dementia Discovery Fund (DDF) and serves on the DDF Investment

  • The world is our laboratory The world is our laboratory

    This year, through J&J Innovation, we will invest $10m into the UK government-led Global Dementia Discovery Fund, supporting innovative research into the area. ... This was set up in 2013 to identify innovative solutions for dementia care.

  • Pharma deals in March 2015 Pharma deals in March 2015

    This month saw GSK invest $25m, J&J $10m and the UK Government $22m into the Dementia Discovery fund, a joint initiative also including Lilly, Biogen and Pfizer to research treatments

More from intelligence
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest appointments

  • New hires at EMA, Gilead and BeiGene New hires at EMA, Gilead and BeiGene

    Most recently, Grant was chief executive officer of the Dementia Discovery Fund (DDF), a specialist venture capital fund focused on therapeutics for age-related dementias and neurodegenerative disease.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Health

Established in 2001, Fishawack Health (FH) is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries....

Latest intelligence

Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...

Quick links